noom glp-1 rx Why We Launched GLP-1RX Noom launches Proactive Health GLP-1

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with type 2 diabetes and obesity or overweight and adults with severe obesity and established cardiovascular disease, and the timeline for future readouts, presentations and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations

The good news is that research shows GLP-1 injections dont directly affect creatinine levels or mess with creatine in your body

Our team helps you verify your benefits at no charge

However, severity and tolerance vary widely from person to person